Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 Sep 1;176(3):855–866. doi: 10.1084/jem.176.3.855

Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen

PMCID: PMC2119366  PMID: 1512548

Abstract

We have investigated the impact of mutations on the binding functions of the phosphocholine (PC)-specific T15 antibody in the absence of antigen selection pressure. The H chain complementarity determining region 2 (CDR2) sequence of T15 antibody was saturated with point mutations by in vitro random mutagenesis. From the mutant library, 289 clones were screened by direct DNA sequencing. The point mutations generated by this method were randomly distributed throughout the CDR2 region and included all kinds of substitutions. 46 unique mutant antibodies, containing one to four point mutations each, were expressed in SP2/0 myeloma cells. Functional analysis on these antibodies has provided insights into several aspects of somatic mutation. (a) The majority (26/46) of mutant antibodies either lost (20/46) or had reduced (6/46) ability to bind PC-protein conjugates or R36a, a PC- expressing strain of Streptococcus pneumoniae. In contrast, none of the mutant antibodies displayed increased binding for these PC antigens. Taken together with calculations of destructive mutations elsewhere in the V region, the data suggest that somatic mutation may cause extensive wastage among B cells during clonal expansion after antigen stimulation. (b) The frequency of binding-loss mutants increased sharply when a second mutation was introduced into the CDR2 sequence; it appears that, in some cases, two or more mutations are needed to destroy binding. (c) The mutant antibodies were tested for their reactivity to 11 non-PC antigens as well as to three PC analogues. None of the mutants gained new reactivity or changed their ability to discriminate structural analogues, supporting the notion that the major role of somatic mutation is to increase or decrease affinity rather than to create new specificities. (d) Mutations in at least five different positions in CDR2 were deleterious, suggesting that these residues may be essential for antigen binding. Three of these positions are novel in that they had not been identified to be important for binding PC by previous crystallographic analysis. (e) Introduction of mutations into two highly conserved residues in CDR2 did not alter the overall conformation of the V region as judged by antiidiotypic analysis, and, in some cases, did not affect the antigen binding function. The results thus indicate that even nonconservative substitutions of invariant residues need not be deleterious, suggesting that their conservation may be due to reasons other than maintaining antibody structure or specificity.

Full Text

The Full Text of this article is available as a PDF (2.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen D., Simon T., Sablitzky F., Rajewsky K., Cumano A. Antibody engineering for the analysis of affinity maturation of an anti-hapten response. EMBO J. 1988 Jul;7(7):1995–2001. doi: 10.1002/j.1460-2075.1988.tb03038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bedwell D. M., Strobel S. A., Yun K., Jongeward G. D., Emr S. D. Sequence and structural requirements of a mitochondrial protein import signal defined by saturation cassette mutagenesis. Mol Cell Biol. 1989 Mar;9(3):1014–1025. doi: 10.1128/mcb.9.3.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev. 1987 Apr;96:23–41. doi: 10.1111/j.1600-065x.1987.tb00507.x. [DOI] [PubMed] [Google Scholar]
  4. Berek C., Milstein C. The dynamic nature of the antibody repertoire. Immunol Rev. 1988 Oct;105:5–26. doi: 10.1111/j.1600-065x.1988.tb00763.x. [DOI] [PubMed] [Google Scholar]
  5. Bernstein F. C., Koetzle T. F., Williams G. J., Meyer E. F., Jr, Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol. 1977 May 25;112(3):535–542. doi: 10.1016/s0022-2836(77)80200-3. [DOI] [PubMed] [Google Scholar]
  6. Bond C. T., Francis R. C., Fernald R. D., Adelman J. P. Characterization of complementary DNA encoding the precursor for gonadotropin-releasing hormone and its associated peptide from a teleost fish. Mol Endocrinol. 1991 Jul;5(7):931–937. doi: 10.1210/mend-5-7-931. [DOI] [PubMed] [Google Scholar]
  7. Brown M., Stenzel-Poore M., Stevens S., Kondoleon S. K., Ng J., Bächinger H. P., Rittenberg M. B. Immunologic memory to phosphocholine keyhole limpet hemocyanin. Recurrent mutations in the lambda 1 light chain increase affinity for antigen. J Immunol. 1992 Jan 15;148(2):339–346. [PubMed] [Google Scholar]
  8. Caton A. J., Brownlee G. G., Staudt L. M., Gerhard W. Structural and functional implications of a restricted antibody response to a defined antigenic region on the influenza virus hemagglutinin. EMBO J. 1986 Jul;5(7):1577–1587. doi: 10.1002/j.1460-2075.1986.tb04399.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cerny J., Wallich R., Hammerling G. J. Analysis of T15 idiotopes by monoclonal antibodies: variability of idiotopic expression on phosphorylcholine-specific lymphocytes from individual inbred mice. J Immunol. 1982 Apr;128(4):1885–1891. [PubMed] [Google Scholar]
  10. Chang S. P., Perlmutter R. M., Brown M., Heusser C. H., Hood L., Rittenberg M. B. Immunologic memory to phosphocholine. IV. Hybridomas representative of Group I (T15-like) and Group II (non-T15-like) antibodies utilize distinct VH genes. J Immunol. 1984 Mar;132(3):1550–1555. [PubMed] [Google Scholar]
  11. Chen C., Stenzel-Poore M. P., Rittenberg M. B. Natural auto- and polyreactive antibodies differing from antigen-induced antibodies in the H chain CDR3. J Immunol. 1991 Oct 1;147(7):2359–2367. [PubMed] [Google Scholar]
  12. Chien N. C., Roberts V. A., Giusti A. M., Scharff M. D., Getzoff E. D. Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5532–5536. doi: 10.1073/pnas.86.14.5532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chothia C., Lesk A. M. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol. 1987 Aug 20;196(4):901–917. doi: 10.1016/0022-2836(87)90412-8. [DOI] [PubMed] [Google Scholar]
  14. Claflin J. L., Berry J., Flaherty D., Dunnick W. Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii. J Immunol. 1987 May 1;138(9):3060–3068. [PubMed] [Google Scholar]
  15. Claflin J. L., Berry J. Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected. J Immunol. 1988 Dec 1;141(11):4012–4019. [PubMed] [Google Scholar]
  16. Claflin J. L., George J., Dell C., Berry J. Patterns of mutations and selection in antibodies to the phosphocholine-specific determinant in Proteus morganii. J Immunol. 1989 Nov 1;143(9):3054–3063. [PubMed] [Google Scholar]
  17. Claflin J. L., Hudak S., Maddalena A., Bender T. Antigen-specific anti-phosphocholine antibodies: binding site studies. J Immunol. 1985 Apr;134(4):2536–2543. [PubMed] [Google Scholar]
  18. Clarke S. H., Huppi K., Ruezinsky D., Staudt L., Gerhard W., Weigert M. Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med. 1985 Apr 1;161(4):687–704. doi: 10.1084/jem.161.4.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Clarke S., Rickert R., Wloch M. K., Staudt L., Gerhard W., Weigert M. The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations. J Immunol. 1990 Oct 1;145(7):2286–2296. [PubMed] [Google Scholar]
  20. Cumano A., Rajewsky K. Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP. EMBO J. 1986 Oct;5(10):2459–2468. doi: 10.1002/j.1460-2075.1986.tb04522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Derbyshire K. M., Salvo J. J., Grindley N. D. A simple and efficient procedure for saturation mutagenesis using mixed oligodeoxynucleotides. Gene. 1986;46(2-3):145–152. doi: 10.1016/0378-1119(86)90398-7. [DOI] [PubMed] [Google Scholar]
  22. Diamond B., Scharff M. D. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5841–5844. doi: 10.1073/pnas.81.18.5841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fish S., Fleming M., Sharon J., Manser T. Different epitope structures select distinct mutant forms of an antibody variable region for expression during the immune response. J Exp Med. 1991 Mar 1;173(3):665–672. doi: 10.1084/jem.173.3.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Foote J., Milstein C. Kinetic maturation of an immune response. Nature. 1991 Aug 8;352(6335):530–532. doi: 10.1038/352530a0. [DOI] [PubMed] [Google Scholar]
  25. French D. L., Laskov R., Scharff M. D. The role of somatic hypermutation in the generation of antibody diversity. Science. 1989 Jun 9;244(4909):1152–1157. doi: 10.1126/science.2658060. [DOI] [PubMed] [Google Scholar]
  26. Gearhart P. J., Bogenhagen D. F. Clusters of point mutations are found exclusively around rearranged antibody variable genes. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3439–3443. doi: 10.1073/pnas.80.11.3439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Getzoff E. D., Tainer J. A., Lerner R. A., Geysen H. M. The chemistry and mechanism of antibody binding to protein antigens. Adv Immunol. 1988;43:1–98. doi: 10.1016/s0065-2776(08)60363-6. [DOI] [PubMed] [Google Scholar]
  28. Glockshuber R., Stadlmüller J., Plückthun A. Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603. Biochemistry. 1991 Mar 26;30(12):3049–3054. doi: 10.1021/bi00226a010. [DOI] [PubMed] [Google Scholar]
  29. Hutchison C. A., 3rd, Nordeen S. K., Vogt K., Edgell M. H. A complete library of point substitution mutations in the glucocorticoid response element of mouse mammary tumor virus. Proc Natl Acad Sci U S A. 1986 Feb;83(3):710–714. doi: 10.1073/pnas.83.3.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kobrin B. J., Buhl S., Shulman M. J., Scharff M. D. A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding. J Immunol. 1991 Mar 15;146(6):2017–2020. [PubMed] [Google Scholar]
  31. Levy N. S., Malipiero U. V., Lebecque S. G., Gearhart P. J. Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. J Exp Med. 1989 Jun 1;169(6):2007–2019. doi: 10.1084/jem.169.6.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Levy S., Mendel E., Kon S., Avnur Z., Levy R. Mutational hot spots in Ig V region genes of human follicular lymphomas. J Exp Med. 1988 Aug 1;168(2):475–489. doi: 10.1084/jem.168.2.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lim H. M., Pène J. J. Mutations affecting the catalytic activity of Bacillus cereus 5/B/6 beta-lactamase II. J Biol Chem. 1989 Jul 15;264(20):11682–11687. [PubMed] [Google Scholar]
  34. Malipiero U. V., Levy N. S., Gearhart P. J. Somatic mutation in anti-phosphorylcholine antibodies. Immunol Rev. 1987 Apr;96:59–74. doi: 10.1111/j.1600-065x.1987.tb00509.x. [DOI] [PubMed] [Google Scholar]
  35. Manser T., Parhami-Seren B., Margolies M. N., Gefter M. L. Somatically mutated forms of a major anti-p-azophenylarsonate antibody variable region with drastically reduced affinity for p-azophenylarsonate. By-products of an antigen-driven immune response? J Exp Med. 1987 Nov 1;166(5):1456–1463. doi: 10.1084/jem.166.5.1456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Marion T. N., Tillman D. M., Jou N. T. Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse. J Immunol. 1990 Oct 1;145(7):2322–2332. [PubMed] [Google Scholar]
  37. McKean D., Huppi K., Bell M., Staudt L., Gerhard W., Weigert M. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1984 May;81(10):3180–3184. doi: 10.1073/pnas.81.10.3180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Morrison S. L., Johnson M. J., Herzenberg L. A., Oi V. T. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6851–6855. doi: 10.1073/pnas.81.21.6851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Morrison S. L., Scharff M. D. Mutational events in mouse myeloma cells. Crit Rev Immunol. 1981 Sep;3(1):1–22. [PubMed] [Google Scholar]
  40. Mulligan R. C., Berg P. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2072–2076. doi: 10.1073/pnas.78.4.2072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Murray R., Hutchison C. A., 3rd, Frelinger J. A. Saturation mutagenesis of a major histocompatibility complex protein domain: identification of a single conserved amino acid important for allorecognition. Proc Natl Acad Sci U S A. 1988 May;85(10):3535–3539. doi: 10.1073/pnas.85.10.3535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Padlan E. A., Cohen G. H., Davies D. R. On the specificity of antibody/antigen interactions: phosphocholine binding to McPC603 and the correlation of three-dimensional structure and sequence data. Ann Inst Pasteur Immunol. 1985 Mar-Apr;136C(2):271–276. doi: 10.1016/s0769-2625(85)80058-1. [DOI] [PubMed] [Google Scholar]
  43. Riechmann L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature. 1988 Mar 24;332(6162):323–327. doi: 10.1038/332323a0. [DOI] [PubMed] [Google Scholar]
  44. Roberts V. A., Iverson B. L., Iverson S. A., Benkovic S. J., Lerner R. A., Getzoff E. D., Tainer J. A. Antibody remodeling: a general solution to the design of a metal-coordination site in an antibody binding pocket. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6654–6658. doi: 10.1073/pnas.87.17.6654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rodwell J. D., Gearhart P. J., Karush F. Restriction in IgM expression. IV. Affinity analysis of monoclonal anti-phosphorylcholine antibodies. J Immunol. 1983 Jan;130(1):313–316. [PubMed] [Google Scholar]
  46. Rudikoff S., Giusti A. M., Cook W. D., Scharff M. D. Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1979–1983. doi: 10.1073/pnas.79.6.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rudikoff S., Pawlita M., Pumphrey J., Heller M. Somatic diversification of immunoglobulins. Proc Natl Acad Sci U S A. 1984 Apr;81(7):2162–2166. doi: 10.1073/pnas.81.7.2162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rudikoff S., Pumphrey J. G. Functional antibody lacking a variable-region disulfide bridge. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7875–7878. doi: 10.1073/pnas.83.20.7875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sablitzky F., Wildner G., Rajewsky K. Somatic mutation and clonal expansion of B cells in an antigen-driven immune response. EMBO J. 1985 Feb;4(2):345–350. doi: 10.1002/j.1460-2075.1985.tb03635.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Satow Y., Cohen G. H., Padlan E. A., Davies D. R. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. J Mol Biol. 1986 Aug 20;190(4):593–604. doi: 10.1016/0022-2836(86)90245-7. [DOI] [PubMed] [Google Scholar]
  51. Segal D. M., Padlan E. A., Cohen G. H., Rudikoff S., Potter M., Davies D. R. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4298–4302. doi: 10.1073/pnas.71.11.4298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sharon J., Gefter M. L., Wysocki L. J., Margolies M. N. Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten. J Immunol. 1989 Jan 15;142(2):596–601. [PubMed] [Google Scholar]
  53. Sharon J. The invariant tryptophan in an H chain V region is not essential to antibody binding. J Immunol. 1988 Apr 15;140(8):2666–2669. [PubMed] [Google Scholar]
  54. Shlomchik M. J., Aucoin A. H., Pisetsky D. S., Weigert M. G. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9150–9154. doi: 10.1073/pnas.84.24.9150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Shlomchik M., Mascelli M., Shan H., Radic M. Z., Pisetsky D., Marshak-Rothstein A., Weigert M. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med. 1990 Jan 1;171(1):265–292. doi: 10.1084/jem.171.1.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Siekevitz M., Kocks C., Rajewsky K., Dildrop R. Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses. Cell. 1987 Mar 13;48(5):757–770. doi: 10.1016/0092-8674(87)90073-0. [DOI] [PubMed] [Google Scholar]
  57. Strickland F. M., Gleason J. T., Cerny J. Serologic and molecular characterization of the T15 idiotype--I. Topologic mapping of idiotopes on TEPC15. Mol Immunol. 1987 Jun;24(6):631–635. doi: 10.1016/0161-5890(87)90044-7. [DOI] [PubMed] [Google Scholar]
  58. Strickland F. M., Gleason J. T., Cerny J. Serologic and molecular characterization of the T15 idiotype--II. Structural basis of independent idiotope expression on phosphorylcholine-specific monoclonal antibodies. Mol Immunol. 1987 Jun;24(6):637–646. doi: 10.1016/0161-5890(87)90045-9. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES